GHI Corporation, a pharmaceutical company, reports the following financial information for the year ended December 31, 2022:

Total Revenue: $4,500,000

Research and Development Expenses: $1,200,000

Selling, General, and Administrative Expenses: $1,000,000

Interest Expense: $75,000

Income Tax Expense: $150,000

Cash and Cash Equivalents: $400,000

Short-term Investments: $300,000

Inventory: $500,000

Total Current Liabilities: $600,000

Total Shareholders’ Equity: $2,000,000

Requirements:

Prepare an income statement for GHI Corporation for the year ended December 31, 2022.

Calculate the operating profit margin.

Determine the net profit margin.

Compute the return on equity (ROE).

Calculate the quick ratio.